Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
RAR-related orphan receptor gamma | 15 | 0 | 0 | 15 |
ATAD5 protein, partial | 6 | 0 | 0 | 6 |
GLS protein | 7 | 0 | 0 | 7 |
Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
Smad3 | 3 | 0 | 0 | 3 |
aldehyde dehydrogenase 1 family, member A1 | 4 | 0 | 0 | 4 |
thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
nuclear receptor subfamily 1, group I, member 3 | 6 | 0 | 0 | 6 |
progesterone receptor | 10 | 0 | 0 | 10 |
EWS/FLI fusion protein | 8 | 0 | 0 | 8 |
retinoic acid nuclear receptor alpha variant 1 | 10 | 0 | 0 | 10 |
retinoid X nuclear receptor alpha | 9 | 0 | 0 | 9 |
estrogen-related nuclear receptor alpha | 11 | 0 | 0 | 11 |
estrogen nuclear receptor alpha | 21 | 0 | 0 | 21 |
peroxisome proliferator activated receptor gamma | 6 | 0 | 0 | 6 |
aryl hydrocarbon receptor | 6 | 0 | 0 | 6 |
chromobox protein homolog 1 | 12 | 0 | 0 | 12 |
thyroid hormone receptor beta isoform 2 | 7 | 0 | 0 | 7 |
peripheral myelin protein 22 | 6 | 0 | 0 | 6 |
cytochrome P450 3A4 isoform 1 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit pi | 7 | 0 | 0 | 7 |
ATP-binding cassette sub-family C member 3 | 0 | 13 | 0 | 13 |
Multidrug resistance-associated protein 4 | 0 | 13 | 0 | 13 |
Solute carrier family 22 member 6 | 0 | 6 | 0 | 6 |
Carbonic anhydrase 12 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 3 |
Bile salt export pump | 0 | 2 | 0 | 2 |
Voltage-dependent calcium channel gamma-2 subunit | 5 | 0 | 0 | 5 |
Bile salt export pump | 0 | 19 | 0 | 19 |
Cytochrome P450 2B1 | 0 | 0 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 3 | 0 | 3 |
Carbonic anhydrase 2 | 0 | 3 | 0 | 3 |
Myoglobin | 0 | 1 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 1 | 2 |
Cytochrome P450 1A2 | 0 | 0 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 9 | 0 | 10 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 7 | 1 | 10 |
Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
Cytochrome P450 2C9 | 0 | 10 | 0 | 11 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 7 | 0 | 0 | 7 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 7 | 0 | 0 | 7 |
UDP-glucuronosyltransferase 1-6 | 0 | 2 | 0 | 3 |
Glutamate receptor 2 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 7 | 0 | 0 | 7 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 9 | 0 | 9 |
Carbonic anhydrase 6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 7 | 0 | 0 | 7 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 8 | 1 | 10 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
Cytochrome P450 2J2 | 0 | 8 | 0 | 8 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit beta-3 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit beta-2 | 7 | 0 | 0 | 7 |
Carbonic anhydrase 9 | 0 | 2 | 0 | 2 |
GABA theta subunit | 7 | 0 | 0 | 7 |
Canalicular multispecific organic anion transporter 1 | 0 | 13 | 0 | 13 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 7 | 0 | 0 | 7 |
Carbonic anhydrase 14 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 1 |
toxin B | 0 | 0 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 7 | 0 | 0 | 7 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
thioredoxin reductase | 6 | 0 | 0 | 6 |
phosphopantetheinyl transferase | 7 | 0 | 0 | 7 |
NFKB1 protein, partial | 4 | 0 | 0 | 4 |
alpha-galactosidase | 1 | 0 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 19 | 0 | 0 | 19 |
cytochrome P450 2C19 precursor | 3 | 0 | 0 | 3 |
flap endonuclease 1 | 6 | 0 | 0 | 6 |
DNA polymerase iota isoform a (long) | 3 | 0 | 0 | 3 |
muscarinic acetylcholine receptor M1 | 5 | 0 | 0 | 5 |
lethal factor (plasmid) | 2 | 0 | 0 | 2 |
Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 2 |
Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 5 | 0 | 0 | 5 |
Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
acetylcholinesterase | 2 | 0 | 0 | 2 |
GLI family zinc finger 3 | 11 | 0 | 0 | 11 |
AR protein | 18 | 0 | 0 | 18 |
thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 12 | 0 | 0 | 12 |
glucocorticoid receptor [Homo sapiens] | 13 | 0 | 0 | 13 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 12 | 0 | 0 | 12 |
IDH1 | 7 | 0 | 0 | 7 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 6 | 0 | 0 | 6 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 11 | 0 | 0 | 11 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
geminin | 14 | 0 | 0 | 14 |
lamin isoform A-delta10 | 14 | 0 | 0 | 14 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
Albumin | 0 | 2 | 0 | 2 |
Urease | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
Tyrosinase | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 0 | 1 | 1 |
Spike glycoprotein | 9 | 0 | 0 | 9 |
Hyaluronate lyase | 0 | 1 | 0 | 1 |
Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
Egl nine homolog 1 | 0 | 0 | 0 | 1 |
Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
pregnane X receptor | 2 | 0 | 0 | 2 |
farnesoid X nuclear receptor | 4 | 0 | 0 | 4 |
pregnane X nuclear receptor | 10 | 0 | 0 | 10 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 10 | 0 | 0 | 10 |
nuclear receptor subfamily 1, group I, member 2 | 6 | 0 | 0 | 6 |
thyroid hormone receptor beta isoform a | 3 | 0 | 0 | 3 |
galanin receptor type 3 | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 10 | 0 | 10 |
Glycine receptor subunit alpha-1 | 0 | 10 | 0 | 10 |
Glycine receptor subunit beta | 0 | 10 | 0 | 10 |
Glycine receptor subunit alpha-2 | 0 | 10 | 0 | 10 |
Glycine receptor subunit alpha-3 | 0 | 10 | 0 | 10 |
ORF73 | 0 | 0 | 1 | 1 |
Potassium channel subfamily K member 3 | 0 | 5 | 0 | 5 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 1 | 2 |
Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
Chain A, HADH2 protein | 3 | 0 | 0 | 3 |
Chain B, HADH2 protein | 3 | 0 | 0 | 3 |
endonuclease IV | 2 | 0 | 0 | 2 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
TDP1 protein | 10 | 0 | 0 | 10 |
regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
peroxisome proliferator-activated receptor delta | 5 | 0 | 0 | 5 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 5 | 0 | 0 | 5 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 4 | 0 | 0 | 4 |
peripheral myelin protein 22 isoform 1 | 5 | 0 | 0 | 5 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
heat shock protein beta-1 | 6 | 0 | 0 | 6 |
survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
TAR DNA-binding protein 43 | 4 | 0 | 0 | 4 |
Multidrug and toxin extrusion protein 1 | 0 | 5 | 0 | 5 |
Aldo-keto reductase family 1 member B10 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 5 | 0 | 6 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 3 | 0 | 3 |
Cytochrome c oxidase subunit 2 | 0 | 2 | 0 | 2 |
Fatty acid-binding protein, liver | 0 | 3 | 0 | 3 |
Transthyretin | 0 | 0 | 1 | 3 |
Albumin | 0 | 5 | 3 | 10 |
Interleukin-8 | 0 | 2 | 0 | 2 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, intestinal | 0 | 4 | 1 | 5 |
Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 4 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 2 | 0 | 2 |
C-X-C chemokine receptor type 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 5 | 0 | 7 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 4 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent betaine transporter | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 7 | 0 | 7 |
Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 4 |
Solute carrier family 22 member 6 | 0 | 7 | 0 | 7 |
Prostaglandin G/H synthase 1 | 0 | 5 | 0 | 7 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A7 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A10 | 0 | 1 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 6 | 0 | 0 | 6 |
Cereblon isoform 4 | 0 | 4 | 0 | 4 |
67.9K protein | 3 | 0 | 0 | 3 |
Choline O-acetyltransferase | 0 | 2 | 0 | 2 |
Protein cereblon | 0 | 4 | 0 | 4 |
Insulin-like growth factor-binding protein 5 | 0 | 0 | 1 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
hypoxia-inducible factor 1 alpha subunit | 5 | 0 | 0 | 5 |
Histone H2A.x | 1 | 0 | 0 | 1 |
Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
Cellular tumor antigen p53 | 6 | 0 | 0 | 6 |
Amyloid-beta precursor protein | 0 | 2 | 0 | 2 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 5 | 0 | 0 | 5 |
Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase VIM-1 | 0 | 1 | 0 | 1 |
Luciferase | 8 | 0 | 0 | 8 |
potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
Solute carrier family 22 member 1 | 0 | 5 | 0 | 5 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
ATP-dependent translocase ABCB1 | 0 | 4 | 0 | 4 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 2 | 0 | 2 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 3 | 0 | 4 |
Delta-type opioid receptor | 0 | 4 | 1 | 6 |
Mu-type opioid receptor | 0 | 5 | 2 | 10 |
Kappa-type opioid receptor | 0 | 3 | 1 | 5 |
Histamine H1 receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 6 | 3 | 10 |
D(3) dopamine receptor | 0 | 3 | 0 | 3 |
Delta-type opioid receptor | 0 | 5 | 1 | 7 |
Kappa-type opioid receptor | 0 | 4 | 0 | 4 |
Kappa-type opioid receptor | 0 | 6 | 1 | 8 |
Mu-type opioid receptor | 0 | 3 | 1 | 6 |
Mu-type opioid receptor | 0 | 5 | 0 | 5 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 6 | 0 | 6 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 7 | 1 | 8 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 1 | 2 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 2 | 2 |
USP1 protein, partial | 5 | 0 | 0 | 5 |
nonstructural protein 1 | 4 | 0 | 0 | 4 |
arylsulfatase A | 6 | 0 | 0 | 6 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
snurportin-1 | 2 | 0 | 0 | 2 |
DNA polymerase kappa isoform 1 | 4 | 0 | 0 | 4 |
muscleblind-like protein 1 isoform 1 | 4 | 0 | 0 | 4 |
Acid-sensing ion channel 3 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 4 |
Epidermal growth factor receptor | 0 | 3 | 0 | 3 |
Albumin | 0 | 0 | 1 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 4 | 0 | 8 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 3 | 0 | 3 |
Caspase-1 | 0 | 4 | 0 | 5 |
Adenosine receptor A2a | 0 | 3 | 0 | 3 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member C3 | 0 | 4 | 0 | 4 |
Caspase-3 | 0 | 4 | 0 | 4 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
Caspase-4 | 0 | 4 | 0 | 4 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Caspase-5 | 0 | 4 | 0 | 4 |
Caspase-9 | 0 | 4 | 0 | 4 |
Acid-sensing ion channel 1 | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 4 | 0 | 4 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
Chain A, PROTEIN (PROTEASE) | 0 | 1 | 0 | 1 |
Chain B, PROTEIN (PROTEASE) | 0 | 1 | 0 | 1 |
Chain A, PROTEIN (PROTEASE) | 0 | 1 | 0 | 1 |
Chain B, PROTEIN (PROTEASE) | 0 | 1 | 0 | 1 |
Chain A, HIV-1 PROTEASE | 0 | 1 | 0 | 1 |
Chain B, HIV-1 PROTEASE | 0 | 1 | 0 | 1 |
Chain A, HIV-II PROTEASE | 0 | 1 | 0 | 1 |
Chain B, HIV-II PROTEASE | 0 | 1 | 0 | 1 |
Chain A, POL polyprotein | 0 | 0 | 1 | 1 |
Chain B, POL polyprotein | 0 | 0 | 1 | 1 |
Chain A, POL polyprotein | 0 | 0 | 1 | 1 |
Chain B, POL polyprotein | 0 | 0 | 1 | 1 |
Chain A, POL polyprotein | 0 | 0 | 1 | 1 |
Chain B, POL polyprotein | 0 | 0 | 1 | 1 |
Chain A, POL polyprotein | 0 | 0 | 1 | 1 |
Chain B, POL polyprotein | 0 | 0 | 1 | 1 |
Chain A, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain B, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain A, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain B, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain A, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain B, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain A, POL polyprotein | 0 | 1 | 0 | 1 |
Chain B, POL polyprotein | 0 | 1 | 0 | 1 |
Chain A, POL polyprotein | 0 | 1 | 0 | 1 |
Chain B, POL polyprotein | 0 | 1 | 0 | 1 |
Chain A, HIV-1 protease | 0 | 1 | 0 | 1 |
Chain B, HIV-1 protease | 0 | 1 | 0 | 1 |
Chain A, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain A, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain A, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain A, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain B, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain B, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain B, Hiv-1 Protease | 0 | 1 | 0 | 1 |
G | 9 | 0 | 0 | 9 |
cytochrome P450 2D6 | 7 | 0 | 0 | 7 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Interferon beta | 11 | 0 | 0 | 11 |
HLA class I histocompatibility antigen, B alpha chain | 9 | 0 | 0 | 9 |
Gag-Pol polyprotein | 0 | 2 | 0 | 2 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Gag polyprotein | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 2 | 0 | 2 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 2 | 0 | 2 |
Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
Thromboxane-A synthase | 0 | 2 | 0 | 2 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
Thromboxane-A synthase | 0 | 0 | 0 | 1 |
Genome polyprotein | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Protease | 0 | 2 | 1 | 5 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 9 | 0 | 0 | 9 |
Protease | 0 | 2 | 1 | 3 |
Protease | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 9 | 0 | 0 | 9 |
Chain A, membrane-associated prostaglandin E synthase-2 | 0 | 1 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 3 | 0 | 0 | 3 |
Chain A, Cruzipain | 1 | 0 | 0 | 1 |
interleukin 8 | 1 | 0 | 0 | 1 |
SMAD family member 2 | 6 | 0 | 0 | 6 |
SMAD family member 3 | 6 | 0 | 0 | 6 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 4 | 0 | 0 | 4 |
estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
Parkin | 2 | 0 | 0 | 2 |
bromodomain adjacent to zinc finger domain 2B | 4 | 0 | 0 | 4 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
cytochrome P450 2C9 precursor | 3 | 0 | 0 | 3 |
vitamin D3 receptor isoform VDRA | 2 | 0 | 0 | 2 |
ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 4 | 0 | 0 | 4 |
neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
Prostaglandin E synthase | 0 | 1 | 0 | 1 |
3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 1 |
Procathepsin L | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 1 | 0 | 2 |
Androgen receptor | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 1 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C4 | 0 | 2 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
Serum paraoxonase/arylesterase 1 | 0 | 4 | 0 | 4 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C2 | 0 | 2 | 0 | 2 |
Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
Prostaglandin D2 receptor | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1A3 | 0 | 2 | 0 | 2 |
Lactoylglutathione lyase | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member C1 | 0 | 2 | 0 | 2 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 1 | 0 | 2 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
Cytosolic phospholipase A2 gamma | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor 2 | 0 | 1 | 1 | 2 |
Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
Chain A, Beta-lactamase | 4 | 0 | 0 | 4 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
Rac1 protein | 0 | 0 | 1 | 1 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
activating transcription factor 6 | 3 | 0 | 0 | 3 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
mitogen-activated protein kinase 1 | 4 | 0 | 0 | 4 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
Cell division control protein 42 homolog | 0 | 1 | 0 | 1 |
Ras-related C3 botulinum toxin substrate 1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase PAK 1 | 0 | 1 | 0 | 1 |
Ataxin-2 | 6 | 0 | 0 | 6 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 9 subunit alpha | 0 | 3 | 0 | 3 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
PPM1D protein | 2 | 0 | 0 | 2 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
Androgen receptor | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 5 | 0 | 0 | 5 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 2 | 0 | 0 | 2 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
Disintegrin and metalloproteinase domain-containing protein 17 | 2 | 0 | 0 | 2 |
Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Opioid receptor homologue | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
Translocator protein | 0 | 0 | 1 | 1 |
Histidine decarboxylase | 0 | 0 | 1 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 2 | 1 | 4 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Hormone-sensitive lipase | 0 | 1 | 0 | 1 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
polyprotein | 1 | 0 | 0 | 1 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 1 | 4 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 3 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Cytochrome P450 2C19 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
MBT domain-containing protein 1 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 4 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 0 | 1 | 1 |
Lethal(3)malignant brain tumor-like protein 3 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 1 | 0 | 1 | 0 | 1 |
15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
GALC protein | 1 | 0 | 0 | 1 |
Bloom syndrome protein isoform 1 | 3 | 0 | 0 | 3 |
histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
Alpha-synuclein | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 11 | 0 | 1 | 0 | 1 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
cGMP-gated cation channel alpha-1 | 0 | 0 | 1 | 1 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
glp-1 receptor, partial | 2 | 0 | 0 | 2 |
procathepsin L isoform 1 preproprotein | 0 | 1 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 1 | 0 | 1 |
Sterol 14-alpha-demethylase | 0 | 0 | 1 | 1 |
14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Cholesterol side-chain cleavage enzyme, mitochondrial | 0 | 0 | 1 | 1 |
Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
Cytochrome P450 144 | 0 | 0 | 1 | 1 |
Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Sterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
Cholesterol 24-hydroxylase | 0 | 2 | 1 | 3 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |